Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2025 Aug 8;16:1672871. doi: 10.3389/fmicb.2025.1672871

Correction: Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review

Sun Rui 1,†,#, Guo Fengrui 2,†,#, Zhang Yining 1, Shao Hong 1, Yang Xuewen 1, Wang Changping 1, Yang Chunjia 2,*
PMCID: PMC12372619  PMID: 40862139

An incorrect number was provided for Heilongjiang Province. The correct number is (2021-KYYWF-0574).

The correct funding statement reads:

The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the Basic Scientific Research Business Expenses of Colleges and Universities in Heilongjiang Province (2021-KYYWF-0574).

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES